This text is a result of machine translation.
Yi Ming ang Ke delivers a statement to the main board of the Hong Kong stock exchange to develop a new generation of tumor immunotherapy
Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China
F-star to be acquired by China biopharmaceutical with USD 161million
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
Research
Consumer Staples, Technology, HealthcareWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Technology, Real Estate, Consumer DiscretionaryTech for Global, Globalization Footprints of the Established and the New
East China medicine "liraglutide" goes to sea
Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care
Baiyunshan: suspension of the spin off of Guangzhou Pharmaceutical for overseas listing
Germany Merck "cetuximab" new indications for head and neck squamous cell carcinoma approved in China
Yanye new crown drug 3CL protein inhibitor has been suspended approval
Waterdrop: The First Crowdfunding Stock?
The company is said to be planning an IPO for early 2021.
Oct 21, 2020 01:07 AM
Insurance Platform Waterdrop to Seek USD 500 Mn New York IPO in 1Q 2021
Tencent, Swiss Re, IDG, Others Invest USD 230 Mn in Insurtech Waterdrop
UXIN Group's Former CTO Joins Waterdrop as Partner